Authors


Ava L. Liberman, MD

Latest:

Assessing In-Hospital Stroke Risk in Pregnant Patients Using Assisted Reproductive Technologies: Ava L. Liberman, MD

The medical director of the Stroke Center at Weill Cornell Medicine talked about results from a recent study on the risk of stroke in patients on assisted reproductive technologies during delivery hospitalization. [WATCH TIME: 4 minutes]


Nathaniel Fletcher Watson, MD

Latest:

Managing Insomnia: Practical Advice for Community Physicians

Closing their discussion on insomnia, panelists share final thoughts and advice for community physicians.


Joohi Jimenez-Shahed, MD

Latest:

Advanced Parkinson Disease: Looking Ahead

Panelists look ahead in the management of advanced Parkinson disease and discuss the promise of different investigational therapies.


Rita Sattler, MD, MSc

Latest:

Future Role of Neurofilament Light in ALS Drug Development, Clinical Trials: Rita Sattler, PhD, MSc

The professor in the Department of Translational Neuroscience at Barrow Neurological Institute provided perspective on the approval of tofersen (Qalsody; Biogen) for patients with ALS and the ways neurofilament light will be used going forward. [WATCH TIME: 3 minutes]


Jacob Pellinen, MD

Latest:

Cenobamate's Efficacy in Drug-Resistant Epilepsy: Jacob Pellinen, MD

The assistant professor of neurology at University of Colorado School of Medicine discussed findings on the impact of cenobamate on hospital visits and emergency care for patients with drug-resistant epilepsy following surgery. [WATCH TIME: 3 minutes]


Brent D. Aulston, PhD

Latest:

Preclinical Research on CRISPR-Based Gene Editing for Alzheimer Disease Treatment: Brent D. Aulston, PhD

The postdoctoral fellow at the University of California San Diego discussed using CRISPR-based gene editing to alter the amyloid precursor protein gene in mice models with symptoms of Alzheimer disease. [WATCH TIME: 5 minutes]


Michael Y. Sy, MD, PhD

Latest:

Addressing the Unmet Needs of Managing MS Symptoms: Michael Y. Sy, MD, PhD

The associate professor of clinical neurology at University of California, Irvine School of Medicine talked about addressing the critical unmet needs in disability progression among patients with multiple sclerosis. [WATCH TIME: 3 minutes]


Bijoy E. John, MD

Latest:

Spring Forward or Fall Back: Time-Change Sleep Problems

Bijoy E. John, MD, founder and medical director of Sleep Wellness Clinics of America (Nashville) and Sleep Fix Academy, discussed the health risks associated with daylight saving time changes.


Mike Hennessy Sr, Founder and Chairman, MJH Life Sciences

Latest:

Questions Linger Around COVID-19’s Origin

Mike Hennessy Sr, Chairman and founder, MJH Life Sciences™, offers his perspective on the questions around the origin of COVID-19 and applauds the extensive efforts to produce vaccines.


Stephanie Teixeira-Poit, PhD

Latest:

Feasibility of Incorporating an Interprofessional Student Program to Other Institutions, Universities: Stephanie Teixeira-Poit, PhD

The associate professor at the North Carolina Agricultural and Technical State University provided insight on the widespread feasibility of a new initiative that aims to teach and attract young professionals to the MS field. [WATCH TIME: 4 minutes]


Shephard Mpofu, MD

Latest:

Published Phase 3 Data Demonstrates Unprecedented Improvements in SMA Type 1 Compared With Natural History

The senior vice president and chief medical officer at Novartis Gene Therapies shared his perspective on the recent clinical trial results for Zolgensma in SMA type 1.


Tanya Simuni, MD, FAAN

Latest:

Next Steps in Bringing PD Staging System to Clinic: Tanya Simunui, MD

The head of the division of movement disorder at the Northwestern University Feinberg School of Medicine discussed the steps necessary in bringing a newly established Parkinson disease defining system to clinical settings. [WATCH TIME: 4 minutes]


Alexandria Reynolds, PhD

Latest:

Building a Healthy Learning Environment for Young Medical Professionals: Alexandria Reynolds, PhD

The undergraduate program director at the University of South Carolina discussed the shift in teaching strategies for those in neurology and why more hands-on experience serves students better. [WATCH TIME: 5 minutes]


Mona Bostick, RDN, LDN, MSCS

Latest:

Enacting Necessary Changes to the MS Care Model: Mona Bostick, RDN, LDN, MSCS

Discussing adaptations to the comprehensive care model in multiple sclerosis, the founder of MS Bites commented on the need to consistently incorporate dietitians. [WATCH TIME: 6 minutes]



Richard Nowak, MD, MS

Latest:

Advancing Research in Myasthenia Gravis With Clinician-Patient Partnership: Richard Nowak, MD, MS

The assistant professor of neurology at the Yale School of Medicine spoke about the strength in the patient-clinician relationship in ensuring quality care for myasthenia gravis. [WATCH TIME: 4 minutes]


Leeron Nahmias, BS

Latest:

Using the Cognitive Stress Test to Distinguish Pre-MCI and Amnestic MCI: Leeron Nahmias, BS

The medical student at Nova Southeastern University provided insight on a new innovative tool called the Cognitive Stress Test that can help distinguish different cognitive states for older adults. [WATCH TIME: 6 minutes]


John Parkinson

Latest:

CDC and FDA Announce Stroke Safety Concern Related to Pfizer-BioNTech Bivalent COVID-19 Vaccine

Despite previous data suggesting no link, the CDC and FDA will continue to review all evidence for possible increased risk of ischemic stroke.


Patrick Kwan, MD, PhD, FRCP

Latest:

Empowering Patient Voice in Epilepsy Treatment and Strategies for Seizure Freedom: Patrick Kwan, MD, PhD, FRCP

The professor of neurology in the department of neuroscience at Monash University discussed implementation strategies for treatment approaches to achieve seizure freedom in patients with epilepsy. [WATCH TIME: 5 minutes]


Sara Pavitt, MD

Latest:

Using a Novel Educational Intervention to Improve Overall Knowledge of Headache: Sara Pavitt, MD

The chief of headache at UT Austin Dell Children’s Hospital provided insight on a new series designed to deliver longitudinal comprehensive pediatric headache education. [WATCH TIME: 3 minutes]


Jessica Caldwell, PhD

Latest:

The Realities of Gender-Targeted Therapeutics for Alzheimer Disease: Jessica Caldwell, PhD

The director of the Women’s Alzheimer’s Movement Preventer Center at Cleveland Clinic provided perspective on the possibility of gender-specific therapies to overcome disparities in Alzheimer disease. [WATCH TIME: 3 minutes]


Jason M. Davies, MD, PhD

Latest:

A Promising New Approach To Reduce Repeat Surgeries for Subdural Hematomas: Jason M. Davies, MD, PhD

The assistant professor of neurosurgery and biomedical informatics at the State University of New York at Buffalo talked about the potential of embolizing the middle meningeal artery in patients with subdural hematomas. [WATCH TIME: 4 minutes]


Ahmed Obeidat, MD, PhD

Latest:

Question and Answer about Neurofilament Light Chain and Other MS Biomarkers

Mark Freedman, MD, MSc, Tanuja Chitnis, MD, and Ahmed Obeidat, MD, PhD, answer questions about biomarkers in MS care.


Cathleen M. Lutz, PhD

Latest:

Understanding Stathmin-2’s Impact on ALS Motor and Sensory Denervation: Cathleen M. Lutz, PhD

The vice president of the Rare Disease Translational Center at the Jackson Laboratory discussed results from a recently published study reinforcing stathmin-2 as a potential therapeutic strategy for ALS. [WATCH TIME: 4 minutes]


Paul G. Mathew, MD, DNPAS, FAAN, FAHS

Latest:

Building the Next Generation of Migraine Specialists: Rashmi B. Halker-Singh, MD, FAAN, and Paul Mathew, MD, DNBPAS, FAAN, FAHS

The chair and vice-chair of the Headache and Facial Pain Section of the American Academy of Neurology provided insight on projects they feel are needed to advance the care of patients with migraine-related disorders. [WATCH TIME: 4 minutes]


Amy Kunchok, MD, PhD

Latest:

Real-World Effectiveness and Safety of Monoclonal Antibodies in NMOSD: Amy Kunchok, MD, PhD

The staff neurologist at the Mellen Center for Multiple Sclerosis at Cleveland Clinic talked about findings from a real-world study assessing novel monoclonal antibodies in patients with NMOSD presented at ACTRIMS Forum 2024. [WATCH TIME: 4 minutes]


Duren M. Ready, MD, FAHS

Latest:

Building Your Acute Migraine Toolbox

Plagued by a long history of under- and inadequate treatment, clinicians have more options than ever to craft a personalized, effective plan for their patients.


Tianrong Yeo, PhD, MBBS, MRCP, MMED, FAMS, MCI

Latest:

Occurrence of Late-Onset Neurotropenia After Anti-CD20 Therapy: Tianrong Yeo, PhD, MBBS, MRCP, MMED, FAMS, MCI

The senior consultant for the department of neurology at the National Neuroscience Institute discussed a report on two patients who developed an uncommon adverse event of late-onset neurotropenia after anti-CD20 therapy treatment. [WATCH TIME: 8 minutes]


Irene Wang, PhD

Latest:

How MR Fingerprinting Can Improve Epilepsy Surgery: Irene Wang, PhD

The research director and staff scientist at Cleveland Clinic’s Epilepsy Center detailed the clinical pre- and post-surgery benefits patients with epilepsy get from MR fingerprinting. [WATCH TIME: 3 minutes]


James E. Galvin, MD, MPH

Latest:

Expanding the Pathways to Treat Dementia With Lewy Bodies: James Galvin, MD, MPH

The director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine detailed the need for improved biomarkers of dementia with Lewy bodies and whether research in Alzheimer disease helps propel the field. [WATCH TIME: 3 minutes]

© 2024 MJH Life Sciences

All rights reserved.